Peripheral artery disease, or PAD, is a condition where the arteries become narrow or blocked over time, most often affecting the legs. Reduced blood flow means that oxygen and other essential ...

Analysis of 160 patients with acute, subacute, or chronic symptoms of thrombotic limb ischemia receiving thromboemboli removal treatment with the Pounce™ Thrombectomy Platform demonstrated high ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Fishing duo Cole and Jay experience an epic fish hook-up that almost snaps a tree in two. Schumer offers plan to end shutdown on Senate floor Chris Hemsworth, Alzheimer's and why Hollywood is suddenly ...

VIENNA — Oral semaglutide showed similar reductions in cardiovascular events in patients with type 2 diabetes (T2D) and cardiovascular or chronic kidney disease with and without peripheral artery ...

For those with severe vascular disease, treatments are limited. But a pioneer procedure is serving as a new “last resort” for those with the disease. WAMC’s Samantha Simmons spoke with some of the ...

Mark W. Feinberg, MD, cardiologist with the Mass General Brigham Heart and Vascular Institute and professor of medicine at Harvard Medical School, is the senior author of a paper published in the ...

Prosthetics like these are helping those with limb differences do the things they’re passionate about. Military MRAP t-bones car in DC amid Trump's national guard deployment Gigantic US Spy Plane ...

Patients with type 2 diabetes (T2D) and peripheral artery disease or diabetic foot ulcers who initiated semaglutide instead of other glucose-lowering medications had a significantly reduced risk for ...

Please provide your email address to receive an email when new articles are posted on . GLP-1s were linked to reduced risk for major adverse CV and limb events at 1 year in patients with moderate ...

Clinical Implications of a Large-Scale Voluntary Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine: Preliminary Results The following represents disclosure ...